Další formáty:
BibTeX
LaTeX
RIS
@article{1357932, author = {Češková, Eva}, article_location = {Abingdon}, article_number = {14}, doi = {http://dx.doi.org/10.1080/14656566.2016.1219340}, keywords = {Depressive disorder; pharmacoresistance; multimodal; multifunctional antidepressants; pharmacogenomic tests}, language = {eng}, issn = {1465-6566}, journal = {EXPERT OPINION ON PHARMACOTHERAPY}, title = {Current pharmacotherapy of depression - focused on multimodal/multifunctional antidepressants}, url = {http://www.tandfonline.com/doi/full/10.1080/14656566.2016.1219340?scroll=top&needAccess=true}, volume = {17}, year = {2016} }
TY - JOUR ID - 1357932 AU - Češková, Eva PY - 2016 TI - Current pharmacotherapy of depression - focused on multimodal/multifunctional antidepressants JF - EXPERT OPINION ON PHARMACOTHERAPY VL - 17 IS - 14 SP - 1835-1837 EP - 1835-1837 PB - TAYLOR & FRANCIS LTD SN - 14656566 KW - Depressive disorder KW - pharmacoresistance KW - multimodal KW - multifunctional antidepressants KW - pharmacogenomic tests UR - http://www.tandfonline.com/doi/full/10.1080/14656566.2016.1219340?scroll=top&needAccess=true L2 - http://www.tandfonline.com/doi/full/10.1080/14656566.2016.1219340?scroll=top&needAccess=true N2 - Major depressive disorder (MDD) is a widespread disease, with a lifetime prevalence of 15% and an annual incidence of approximately 7%. It is associated with significant costs in quality of life, loss of work productivity, and a high risk of mortality. It is predicted to become the leading cause of disability in Western countries by 2030. ER -
ČEŠKOVÁ, Eva. Current pharmacotherapy of depression - focused on multimodal/multifunctional antidepressants. \textit{EXPERT OPINION ON PHARMACOTHERAPY}. Abingdon: TAYLOR \&{} FRANCIS LTD, 2016, roč.~17, č.~14, s.~1835-1837. ISSN~1465-6566. Dostupné z: https://dx.doi.org/10.1080/14656566.2016.1219340.
|